PHARMA-BIO SERV, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
PHARMA-BIO SERV, INC. (PBSV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.55 per share for the 12-month period ending 2015-10-31, per its 10-K filed 2016-01-29.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2016-01-29
- PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $0.55, a 29.99% decline from fiscal 2014.
- PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2014 was $0.78, a 212.87% increase from fiscal 2013.
- PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2013 was $0.25, a 12.03% increase from fiscal 2012.
- PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2012 was $0.22, a 71.44% increase from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2015-10-31 | $0.55 10-K · filed 2016-01-29 |
| 2014-10-31 | $0.78 10-K · filed 2016-01-29 |
| 2013-10-31 | $0.25 10-K · filed 2015-01-29 |
| 2012-10-31 | $0.22 10-K · filed 2014-01-29 |
| 2011-10-31 | $0.13 10-K · filed 2013-01-29 |